Clinical Trial Update: Contrast-medium Induced Nephrotoxicity in Patients Undergoing Coronary Angiography - Iodixanol Versus Iopromide [Phase 4]

View source ↗

Summary

Phase 4 trial comparing iodixanol and iopromide for contrast-induced nephrotoxicity in patients with chronic kidney disease undergoing coronary angiography; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Coronary Artery Disease

Drugs mentioned

• IODIXANOL (IODIXANOL)
• Iopromide (iopromide)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Chronic Renal Insufficiency, Coronary Angiography | Phase 4 | Status: COMPLETED